ALK-negative anaplastic large cell lymphoma with "Hodgkin-like" cytomorphology and nuclear expression of PAX5

被引：2

作者：

Fratoni, Stefano ^{[1
]}

Niscola, Pasquale ^{[2
]}

Zhao, Xiangfeng Frank ^{[3
]}

Larocca, Luigi Maria ^{[4
]}

Capalbo, Anna ^{[5
]}

Fabbretti, Maria ^{[4
]}

Bernardini, Laura ^{[6
]}

Abruzzese, Elisabetta ^{[2
]}

机构：

[1] St Eugenio Hosp, Dept Surg Pathol Hematopathol, Rome, Italy

[2] St Eugenio Hosp, Hematol Unit, Rome, Italy

[3] Univ Arizona, Coll Med, Phoenix VA Healthcare Syst Pathol & Lab Med Serv, Dept Pathol, Phoenix, AZ USA

[4] Catholic Univ, Dept Surg Pathol, Rome, Italy

[5] Casa Sollievo Sofferenza IRCCS Fdn, Cytogenet Unit, San Giovanni Rotondo, Italy

[6] CSS Mendel Inst, Rome, Italy

来源：

PATHOLOGY RESEARCH AND PRACTICE | 2020年 / 216卷 / 02期

关键词：

ALK-negative anaplastic large cell lymphoma; Hodgkin-like" features; PAX5;

D O I：

10.1016/j.prp.2019.152724

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

Anaplastic lymphoma kinase negative systemic anaplastic large cell lymphoma (ALK-ALCL) is a CD30 + T-cell malignant lymphoma which may involve both lymph nodes and extranodal tissues, showing important clinical differences from ALK-positive ALCL (ALK + ALCL). ALK- ALCL is considered a specific entity by the 2016 World Health Organization (WHO) classification of hematolymphoid neoplasms. We describe an exceptional case of ALK- ALCL with a striking "Hodgkin-like" cytomorphology and a very uncommon nuclear expression of PAX5.

引用

页数：5

共 50 条

[31] Occult ALK-negative anaplastic large cell lymphoma complicating chronic lymphocytic leukemia
Ahmed, Reham
Feldman, Andrew L.
BLOOD, 2024, 143 (10) : 938 - 938
[32] Targetable fusions of the FRK tyrosine kinase in ALK-negative anaplastic large cell lymphoma
Hu, G.
Dasari, S.
Asmann, Y. W.
Greipp, P. T.
Knudson, R. A.
Benson, H. K.
Li, Y.
Eckloff, B. W.
Jen, J.
Link, B. K.
Jiang, L.
Sidhu, J. S.
Wellik, L. E.
Witzig, T. E.
Bennani, N. N.
Cerhan, J. R.
Boddicker, R. L.
Feldman, A. L.
LEUKEMIA, 2018, 32 (02) : 565 - 569
[33] BRENTUXIMAB VEDOTIN FOR T-CELL LYMPHOMA: A CASE OF ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA (ALCL)
Sumbly, V.
Landry, I.
Rizzo, V.
JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (04) : 1155 - 1155
[34] Primary bone anaplastic large cell lymphoma of lymphohistiocytic variant, ALK-negative: A challenging diagnosis
Karube, Kennosuke
Nakada, Norihiro
Yamamoto, Hidetaka
PATHOLOGY INTERNATIONAL, 2020, 70 (06) : 376 - 378
[35] Images from the Haematologica Atlas of Hematologic Cytology: anaplastic large cell lymphoma, ALK-negative
Invernizzi, Rosangela
HAEMATOLOGICA, 2022, 107 (12) : 2771 - 2771
[36] Molecular Predictors of Treatment Failure in ALK-Negative Anaplastic Large T-Cell Lymphoma
Gorenkova, Liliya
Kravchenko, Sergey Kirillovich
Mkrtchyan, Asmik
Musyirin, Vsevolod
Misyurina, Anna Evgenevna
Savchenko, Valeriy G.
BLOOD, 2016, 128 (22)
[37] ALK-negative T-cell anaplastic large cell lymphoma associated with systemic lupus erythematosus
Suvajdzic, N
Stpjanovic-Milenkovic, R
Tomasevic, Z
Cemerikic-Martinovic, V
Mikhaljevic, B
Atkinson, HDE
MEDICAL ONCOLOGY, 2003, 20 (04) : 409 - 412
[38] Recurrent ALK-Negative Anaplastic Large T-Cell Lymphoma Presenting as Necrotizing Vasculitis
Nambudiri, Vinod E.
Aboutalebi, Amir
Granter, Scott R.
Saavedra, Arturo
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2013, 35 (04) : 512 - 516
[39] ALK-negative T-cell anaplastic large cell lymphoma associated with systemic lupus erythematosus
Nada Suvajdzic
Roksanda Stojanovic-Milenkovic
Zoran Tomasevic
Vesna Cemerikic-Martinovic
Biljana Mihaljevic
Henry D. E. Atkinson
Medical Oncology, 2003, 20 : 409 - 412
[40] Bcl-2 is expressed in ALK-negative but not ALK-positive anaplastic large cell lymphoma (ALCL).
Rassidakis, GZ
Medeiros, LJ
Herling, M
Ford, R
Messina, O
Cabanillas, F
Sarris, AH
BLOOD, 2000, 96 (11) : 128A - 128A

← 1 2 3 4 5 →